Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Pfizer’s arthritis drug Enbrel widens its European licence

Gains new indication for early-stage inflammatory joint disease

Sanofi reception

Sanofi and Regeneron pay $67.5m to speed alirocumab review

Buy FDA priority review voucher from BioMarin

- PMLiVE

Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head

Moves to the Boston company from Onyx Pharmaceuticals

Fishawack buys UK med comms agency Facilitate

Dealis the Fishawack Group's third in just over a year

Roche Basel Switzerland

Roche pays $450m for ‘gene-silencing’ firm Santaris Pharma

Deal marks major return to the RNAi field it exited four years ago

- PMLiVE

UCB joins clinical trial data sharing portal

Follows GSK, Lilly, Roche and others in committing to transparency website

- PMLiVE

Bioinformatics firm Eagle adds to senior team

Appoints Michael Reynolds and promotes Will Spooner and Glenn Proctor

Bristol-Myers Squibb (BMS) building

BMS creates US academic tie-up to foster biopharma research

Partnership with investment firm could also boost its pipeline

- PMLiVE

Amgen closes on second-line use for Kyprolis

Multiple myeloma therapy posts positive interim phase III results

Boehringer Ingelheim headquarters

FDA approves Boehringer COPD spray Striverdi Respimat

Licence from US regulator will also allow it to treat chronic bronchitis or emphysema

UK Life Sciences Strategy - one year on

UK invests in genetic research for cancer and rare diseases

Government outlines £300m boost for 100,000 Genomes Project

- PMLiVE

Boehringer/Lilly’s Jardiance approved in US

But the FDA wants four post-marketing studies of the SGLT-2 diabetes drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links